Developing new drugs is not for the faint-hearted. “It’s a pretty perilous journey,” says Paul Nioi, vice-president of discovery and translational research at Alnylam Pharmaceuticals. “It’s expensive ...
Ferns, defined by large genomes, high chromosome counts, and pervasive aneuploidy as well as intraspecific polyploid complexity, diverge significantly from the classical genetic theories and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results